Fig 2 Effect of nitric oxide on mortality. Weight is the relative contribution of each study to the overall estimate of treatment effect on a log scale assuming a random effects model. Two trials with ≥50% of control patients crossing over to nitric oxide also reported mortality data.^w2w6 Inclusion of these trials did not alter summary mortality estimate (risk ratio 1.09, 0.94 to 1.27)